Stocks and Investing Stocks and Investing
Thu, March 2, 2023

Serge Belanger Maintained (XENE) at Strong Buy with Increased Target to $50 on, Mar 2nd, 2023


Published on 2024-10-28 02:03:28 - WOPRAI, Serge Belanger
  Print publication without navigation


Serge Belanger of Needham, Maintained "Xenon Pharmaceuticals Inc." (XENE) at Strong Buy with Increased Target from $48 to $50 on, Mar 2nd, 2023.

Serge has made no other calls on XENE in the last 4 months.



There are 5 other peers that have a rating on XENE. Out of the 5 peers that are also analyzing XENE, 0 agree with Serge's Rating of Hold.



These are the ratings of the 5 analyists that currently disagree with Serge


  • Brian Abrahams of "RBC Capital" Maintained at Buy with Increased Target to $51 on, Tuesday, January 31st, 2023
  • Paul Choi of "Goldman Sachs" Initiated at Strong Buy and Held Target at $60 on, Wednesday, December 14th, 2022
  • Joseph Thome of "Cowen & Co." Initiated at Buy on, Monday, December 12th, 2022
  • Mohit Bansal of "Wells Fargo" Initiated at Buy and Held Target at $50 on, Monday, November 28th, 2022
  • Yatin Suneja of "Guggenheim" Maintained at Strong Buy with Decreased Target to $49 on, Friday, November 11th, 2022
Contributing Sources